Cargando…
On-site bundled rapid HIV/HCV testing in substance use disorder treatment programs: study protocol for a hybrid design randomized controlled trial
BACKGROUND: More than 1.2 million people in the United States are living with human immunodeficiency virus (HIV), and 3.2 million are living with hepatitis C virus (HCV). An estimated 25 % of persons living with HIV also have HCV. It is therefore of great public health importance to ensure the promp...
Autores principales: | Frimpong, Jemima A., D’Aunno, Thomas, Perlman, David C., Strauss, Shiela M., Mallow, Alissa, Hernandez, Diana, Schackman, Bruce R., Feaster, Daniel J., Metsch, Lisa R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776446/ https://www.ncbi.nlm.nih.gov/pubmed/26936623 http://dx.doi.org/10.1186/s13063-016-1225-4 |
Ejemplares similares
-
Spillover effects of HIV testing policies: changes in HIV testing guidelines and HCV testing practices in drug treatment programs in the United States
por: Frimpong, Jemima A., et al.
Publicado: (2016) -
Hepatitis C testing in substance use disorder treatment: the role of program managers in adoption of testing services
por: Frimpong, Jemima A., et al.
Publicado: (2016) -
Workforce Diversity and disparities in wait time and retention among opioid treatment programs
por: Guerrero, Erick G., et al.
Publicado: (2022) -
Insights from a national survey into why substance abuse treatment units add prevention and outreach services
por: Wells, Rebecca, et al.
Publicado: (2006) -
The structural and health policy environment for delivering integrated HIV and substance use disorder treatments in Puerto Rico
por: Leff, Jared A., et al.
Publicado: (2017)